The Wilms' tumor suppressor gene, wt1, encodes a zinc finger transcription factor which has been shown to regulate the expression of several genes involved in cellular proliferation and differentiation. Expression of wt1 is developmentally regulated and restricted to a small set of tissues which include the fetal urogenital system, mesothelium and spleen. A highly conserved motif within the wt1 promoter, located between nucleotides -34 and -71 relative to the first transcription start site in the murine promoter, harbors consensus binding sites for Sp1 and members of the paired-box transcription factor family. Pax-2 and Pax-8 are known to enhance expression of wt1 through this conserved regulatory element. In this report, we demonstrate that Sp1 is able to bind to two sites within the 38 bp conserved region (CR). By electrophoretic mobility shift assays (EMSAs), we have identified a novel binding activity, referred to as complex D, which recognizes sequences overlapping one of the Sp1 sites in the CR. EMSA competition experiments indicate that binding of complex D and Sp1 to the CR is mutually exclusive and Sp1 is able to displace complex D binding. In situ UV crosslinking and molecular mass determinations indicate that complex D is a complex of ∼130 kDa, consisting of at least two proteins of ∼62 and ∼70 kDa. Transient transfections suggest that complex D may function as an activator.
INTRODUCTION
Wilms' tumour (WT) is a malignancy which affects 1 in 10 000 children, usually before the age of five years (1) . Wt1, a WT suppressor gene from chromosome 11p13, was identified through the study of hereditary cases of WT showing cytogenetic deletions at 11p13 (for a review, see ref.
2). Wt1 encodes a transcription factor with four zinc finger motifs, three of which show homology to the early growth response (EGR) family of Cys 2 -His 2 zinc fingers and regulates the expression of several genes involved in cellular proliferation or differentiation (2) . Depending on the architecture of the promoter, WT1 can act as either a transcriptional repressor or activator (2) .
Expression of wt1 is regulated both temporally and spatially during development of the urogenital system (3, 4) . Wt1 mRNA is present in tissues of mesodermal origin that undergo a mesenchymal to epithelial transition, with high levels of wt1 mRNA in fetal kidneys, spleen, ovaries and testis (3, 4) . In the fetal kidneys, the highest levels of wt1 mRNA are detected during active nephrogenesis, when mesenchymal cells differentiate into epithelial cells (3) . Upon completion of this transition, the levels of wt1 decrease dramatically (3, 4) . Wt1 is also expressed in the undifferentiated gonad during embryogenesis, and then becomes restricted to granulosa and epithelial cells of the adult ovaries and to the Sertoli cells of the adult testis (3, 4) . These results suggest a functional role for WT1 in the inductive processes of urogenital development. Consistent with this idea is the observation that wt1-null mice fail to develop kidneys and gonads (5) . Germline wt1 lesions in humans are associated with predisposition to WTs and aberrant differentiation of the urogenital system (6) .
The murine wt1 promoter has three transcription initiation sites surrounded by sequences of high GC content (4) . Neither human nor murine promoters contain a typical TATA box, CCAAT site, or Initiator element (4, 7) . A hematopoietic-specific enhancer is located in the 3′-end of the human wt1 gene, >50 kb downstream from the promoter (8) . The hematopoietic-specific transcription factor, GATA-1, has been shown to trans-activate wt1 expression through this enhancer, implying that GATA-1 plays a role in the regulation of wt1 during hematopoiesis (9) . Similar to many other TATA-less, GC-rich promoters with multiple transcriptional start sites, the wt1 promoter contains several binding sites for Sp1 (7, 10) . Sp1 can trans-activate wt1 expression in transient transfections (7, 10) .
A highly conserved 38 bp motif has been identified in the human and murine wt1 promoters immediately upstream of the first transcription initiation start site in the murine promoter (11, 12) . Sequence analysis of this conserved region (CR) indicates the presence of putative binding sites for the transcription factors Sp1, Pax-2 and Pax-8 (11, 12) . Electrophoretic mobility shift assays (EMSAs), transfection studies and analysis of the endogenous wt1 promoter have demonstrated that Pax-2 and Pax-8 can activate wt1 expression through the CR (11, 12) . In this report, we identify and characterize a novel binding activity on the CR element. (25) . The 38 bp CR is located between nucleotides -34 and -71, inclusive, and the proximal (P) and distal (D) subelements are represented by hatched and blackened boxes, respectively. A comparison of the human and murine CR nucleotide sequence is shown. The single nucleotide difference between the two species, a C in the murine promoter compared to a T in the human promoter, is denoted by asterisks. Sp1 binding sites are boxed and Pax binding motifs are underlined. (B) EMSA of subregion D incubated with nuclear extracts prepared from SVGC cells. 32 P-labeled wild-type probe consisting of D (lanes 1-5) and P (lane 6) elements were incubated with SVGC nuclear extract (lanes 1-4, 6) with or without cold competitor oligonucleotide (150-fold molar excess), as described in Materials and Methods. The nature of the DNA probes, competitor oligonucleotides and reactions containing nuclear extract are indicated above each lane. The position of specific and non-specific complexes obtained with D probe are indicated to the left with arrows and arrowheads, respectively. The position of complex D is marked by a dot. Binding reactions were electrophoresed on a 4% non-denaturing polyacrylamide gel and visualized by autoradiography by exposing the X-Omat film (Kodak) at -70_C for 2 h. The bottom inset represents a reduced exposure of the lower portion of the figure to better discriminate between complex VI and free probe, obtained from an overnight exposure of the X-Omat film (Kodak) at room temperature. (C) EMSA of subregion D incubated with SVGC nuclear extracts in the presence of 0.5% sodium desoxycholate and 0.75% NP-40. 32 P-labeled D probe (lanes 1-3) was incubated with SVGC nuclear extract in the presence or absence of unlabeled competitor oligonucleotide, as described in Materials and Methods. The nature of the DNA probes and competitor oligonucleotides are indicated above each lane. The position of specific and non-specific complexes obtained with D probe are indicated to the left with arrows and arrowheads, respectively.
MATERIALS AND METHODS

Preparation of nuclear extracts and EMSA
Nuclear extracts from cell lines grown in culture were prepared according to Dignam et al. (13) . Protein concentrations were determined using the Coomassie protein assay reagent from Pierce (Rockford, IL). EMSAs were performed using 3-6 µg of nuclear protein extract. Oligonucleotide probes were labeled by back-filling with the Klenow fragment of DNA polymerase I using [α-32 P]dCTP (New England Nuclear; 3000 Ci/mmol) or by end labeling with T4 polynucleotide kinase using [γ-32 P]ATP (New England Nuclear; 3000 Ci/mmol). Protein was incubated with 0.02-0.04 pmol of probe (20 000-200 000 c.p.m.) for 20 min at room temperature in the presence of 50 mM HEPES (pH 7.9), 50 mM KCl, 5 mM MgCl 2 , 10 mM ZnSO 4 , 1 mM DTT, 12% glycerol, 1 µg poly dI-dC, 100 ng pBluescript KS II+ and 1 mM spermidine. For competition experiments, reaction mixtures were preincubated for 15 min with 150-fold molar excess of unlabeled 11) prior to the addition of the D probe. The region of the gel containing Sp1 supershifted complexes is delineated to the left by a bracket. Binding reactions were electrophoresed on a 4% non-denaturing polyacrylamide gel and visualized by autoradiography by exposing the X-Omat film (Kodak) at -70_C overnight with an intensifying screen. The bottom inset represents a reduced exposure of the lower portion of the figure to better discriminate between complex VI and free probe, obtained from an overnight exposure of the X-Omat film (Kodak) at room temperature.
oligonucleotides prior to the addition of radiolabeled probes. Oligonucleotide sequences are: CR, 5′-GATCGTC-CCGCCCTCTTGGAGCCCACCTGCCCCTCCCTCCA-3′; D, 5′-TCGAGTTCCCGCCCTCTTGGAGCC-3; P, 5′-TCGACAC-CTGCCCCTCCCTCCA-3′; Sp1-binding site oligo (Sp1), 5′-ATT-CGATCGGGGCGGGGCGAGC-3′; mutant Sp1-binding site oligo (µSp1), 5′-ATTCGATCGGTTCGGGGCGAGC-3′ . For supershift experiments, reaction mixtures were preincubated with 2 µg of anti-Sp1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) or non-immune serum for 1 h on ice prior to the addition of radiolabeled probes. Samples were electrophoresed through a 4% non-denaturing polyacrylamide gel (acrylamide:bisacrylamide ratio, 29:1) at 146 V in 0.5× TBE for 2.5 h at 4_C. After electrophoresis, the gels were dried and subjected to autoradiography against X-Omat film (Kodak, Rochester, New York). 
In situ UV crosslinking
HeLa nuclear extract (3 µg) was preincubated with unlabeled proximal subfragment (P) oligonucleotide (Fig. 1A) (to compete Sp1 binding), then with a radiolabeled, bromodeoxyuridine-substituted distal subfragment (D) oligonucleotide (Fig. 1A) . The binding reaction was electrophoresed through a 1% low melting point agarose gel in 0.5× TBE at 90 V for 4.5 h at 4_C. The wet gel was exposed to film overnight at 4_C. Crosslinking of protein to DNA was then performed in situ by exposing to UV light (312 nm) for 12 min at 4_C. Bands corresponding to complex D and to the free probe were excised by aligning the wet gel with the developed autoradiograph. The agarose gel slices were melted at 65_C for 5 min and SDS sample buffer was added to each sample and heated at 95_C for 3 min. A 30 µl aliquot of each sample was electrophoresed at 25 mA through an 8% SDS-polyacrylamide gel with high range molecular mass markers (BioRad, Mississauga, Ontario). After electrophoresis, the gel was stained with Coomassie blue, destained, dried and exposed to film at -80_C for 7 days with an intensifying screen.
Molecular mass determination by electrophoresis through non-denaturing polyacrylamide gels
The procedure used for determining molecular weight in a non-denaturing system is a modification of the methods of Bryan and Davis (14, 15) . Protein standards were electrophoresed on a set of non-denaturing polyacrylamide gels of differing polyacrylamide concentrations at 146 V in 0.5× TBE at 4_C. The electrophoretic mobility (R F ) of the proteins in each gel was determined relative to the tracking dye (Bromophenol Blue). The function 100Log(R F × 100) was then plotted against the percent gel concentration for each protein, and slopes representing the Retardation Coefficients (K R ) were determined. The logarithm of the negative slopes was plotted against the logarithm of the molecular masses of each protein to produce a linear molecular mass calibration curve. Protein standards used were from the non-denatured protein molecular mass marker kit (Sigma, Mississauga, Ontario) ( Table  1) . To determine the R F of complex D, EMSAs, performed with SVGC extracts and probe D in the presence of competitor P, were electrophoresed on the same set of non-denaturing polyacrylamide gels as the protein standards, and the migration of complex D relative to the tracking dye was calculated. The K R for complex D was then used to extrapolate its molecular weight from the molecular weight calibration curve (Fig. 6A ).
Transfections and CAT assays
For transient transfections, 293 cells were plated at a density of 6 × 10 5 cells per 100 mm dish 24 h prior to transfection. Cells were transfected by the calcium phosphate precipitation method (11, 12) . Reporter vectors used in the transfections were constructed as follows: a SalI-BamHI fragment containing six copies of the D-binding site, derived from the plasmid Bluescript II KS/6×D (M.T.D., unpublished data), was cloned into the SalI-BglII sites of pβCAT (pβCAT/6×D). Oligonucleotides containing three copies of the M4 and M6 binding sites were cloned into the SalI site of pβCAT and clones were identified that contained six copies of M4 or M6 (pβCAT/6×M4 and pβCAT/6×M6). The integrity of the recognition sites was confirmed by DNA sequencing. At 48 h after transfection, cells were harvested and assayed for β-galactosidase and CAT activity (11, 12 
RESULTS
Identification of a novel binding activity to the WT1 promoter
The CR element has been previously described and shown to mediate Pax-responsiveness to the wt1 promoter (Fig. 1A) (11, 12) . For studies described herein, the CR was subdivided into two fragments, distal (D) and proximal (P), both of which contain binding sites for Sp1 and paired-box proteins (Fig. 1A) . During the course of characterizing the wt1 promoter region, we noted a novel binding activity to the D region of the CR motif (Fig. 1B) . EMSAs using nuclear extracts prepared from granulosa SVGC cells [a line which expresses high levels of wt1 mRNA (J.P., data not shown)] and employing a DNA probe encompassing the distal (D) CR subfragment probe, revealed a small set of binding activities ( One interpretation of these results is that addition of excess oligonucleotide P to EMSAs involving probe D or CR prevents binding of a factor which normally competes with complex D for DNA binding. This might occur in a situation where DNA binding by complex D is sterically prevented by another factor bound to probe D. When binding of this factor is prevented (as in competition experiments with P), complex D is capable of assembly onto the D template. Since the above EMSA was performed under conditions of limiting probe concentrations, we repeated the EMSAs under conditions of probe excess. In the presence of sodium desoxycholate, which was added to minimize protein-protein interactions (16), SVGC cell extracts produced a subset of the complexes observed in Figure 1B (Fig. 1C, lane 2) . Complexes I/II, *, V and D were identified by their relative position of migration and by their behaviour to competition by oligonucleotides P and D (Fig. 1C, compare lanes 1 and 3 with 2) . Complex * is not visible in the exposure of Figure 1B , but is present on a longer exposure (M.T.D. and J.P., data not shown). It migrates faster than complex III and is specifically competed by oligonucleotides D and P (see below in Fig. 2 ). Under these conditions, complex D can form on probe D in the absence of competitor P (Fig. 1C, lane 2) . In the current study we have sought to better characterized complex D.
Preventing Sp1 binding allows complex D formation
The presence of Sp1 sites within the D and P subelements (Fig.  1A) lead us to investigate whether any of the complexes observed by EMSA contained Sp1 and whether inhibition of Sp1 binding to probe D would allow complex D formation. To this end, we performed competition experiments with oligonucleotides harbouring Sp1-binding sites as well as 'Sp1 supershift' experiments with anti-Sp1 antibodies (Fig. 2) . In these experiments, we used either limiting amounts of D (lanes 1-6) or P (lanes 7-12) probes. The position of migration of uncomplexed D or P probe is established from lanes 6 and 12, respectively. When nuclear extract was added to D probe, seven complexes were obtained ( Fig. 2, lane 1) . Complex * is clearly visible in this experiment (lane 1). As previously shown in Figure 1B EMSA competition and supershift experiments using the P subfragment as a probe demonstrated a set of complexes with similar behaviour to those obtained with probe D (lanes 7-11) . The notable exception is the failure to observe formation of complex D on probe P under any of the conditions examined.
These results are consistent with the interpretation that the increased binding activity of complex D, observed in the presence of unlabeled P or Sp1 competitor oligonucleotides, is due to the prevention of Sp1 binding to the target probe, D. By inference, we conclude that the complex D binding site must overlap with, or is in sufficiently close proximity to, the Sp1 binding site on the D oligonucleotide, such that binding of both proteins is mutually exclusive. Alternatively, competition with the Sp1 oligonucleotide generates free probe, which can be used as template for complex D formation. This second scenario need not invoke overlapping binding sites for Sp1 and complex D.
Nucleotide sequence requirements for complex D binding
To determine if the complex D and Sp1 sites overlapped, we performed a series of EMSAs with oligonucleotide probes containing different point mutations spanning the length of probe D (Fig.  3 ). Mutants which were tested are illustrated in Figure 3 (M1-M8) . These mutant probes were incubated with SVGC nuclear protein extract to determine the effect of the different mutations on complex D and Sp1 binding (Fig. 4) . Figure 4 and summarized in Figure 3 . A mutation in the Pax binding site (oligonucleotides M1 and M2) or at nt -67 of the D element (oligonucleotide M3), has no effect on the formation of complex D or on Sp1 binding (Fig.  4A-C) . For simplicity of analysis, we have focused our attention on the behaviour of complexes I and II (arrowheads in Fig. 4 ) and complex D (indicated by arrows). Although M3 alters the first cytosine residue of the consensus Sp1 site (Fig. 3) , Sp1 sites are quite 'plastic' and adenosine residues in this position have been documented in Sp1 sites within the HIV LTR (17) . As observed, we therefore expect Sp1 to bind to M3 (Fig. 4C) . We note that complex D formation is observed when wild-type and mutant Sp1-binding site oligonucleotides are used in competition assays (lanes 3 and 4) . In the case of competition with µSp1, binding of complex D is likely due to the generation of free probe. Oligonucleotides M4 and M5, which mutate nucleotides within the Sp1 binding site (Fig. 3) , are unable to bind Sp1 or complex D (Fig. 4D and E) . The M6 oligonucleotide, which contains mutations adjacent to the Sp1 binding site, is capable of binding Sp1 but not complex D (Fig. 4F) . Mutagenesis of nucleotides -56 and -57 (oligonucleotide M7) and -54 and -55 (oligonucleotide M8) of the CR had no effect on the binding activities of Sp1 and complex D (Fig. 4G and H) . Supershift results obtained with anti-Sp1 antibodies are consistent with the competition experiments using the Sp1-binding site oligonucleotide. Again, only complex I is supershifted in these assays (lanes 5). These results define the sequence spanning from nucleotides -66 to -59 of the CR as the binding site for complex D and directly demonstrate that the complex D binding site overlaps with the Sp1 binding site. The fact that these two sites overlap makes steric interference the likely mechanism which prevents simultaneous binding of both factors to probe D.
To determine if Sp1 could directly compete for DNA binding with complex D, we prepared a nuclear protein fraction enriched for complex D binding activity and reduced for Sp1 binding activity (described in the legend to Fig. 5 ). The partially purified activity was used in an EMSA competition experiment with recombinant human Sp1 (Fig. 5) . The position of migration of complex D was defined by control EMSAs performed in parallel with crude HeLa nuclear extracts in the presence or absence of competitor P (M.T.D., data not shown). Partially purified complex D retained a small amount of Sp1 binding activity (Fig. 5, lane 1) . This was confirmed by western blotting of this extract using anti-Sp1 antibodies (M.T.D., data not shown). Adding increasing amounts of recombinant Sp1 to the D probe results in decreased formation of complex D (Fig. 5, lanes  1-4; note that complex D is slightly smeared in this experiment), indicating that Sp1 can displace complex D.
Tissue and species distribution of complex D
In order to characterize the tissue and species distribution of complex D, EMSAs were performed with nuclear extracts prepared from a variety of cell lines utilizing the wild-type D subfragment of the CR as a probe and competing with the P subfragment to enhance the formation of complex D. Table 2 presents a summary of the results obtained from these EMSAs. Factor D binding activity was present in almost all the cell lines tested, with the exception of the Chinese hamster ovary cell line, LR73. Therefore, complex D is expressed in a large number of cell lines and does not show the tissue-restricted expression profile of WT1 (3, 4) . Whether LR73 cells fail to express components of complex D (see below) or generate a form of complex D inactive for DNA binding remains to be established. 
Molecular mass determination of complex D
The native molecular mass of complex D was estimated by non-denaturing polyacrylamide gel electrophoresis as described in Materials and Methods. A calibration curve of K R versus molecular mass was obtained using molecular mass protein standards (Table 1 and Fig. 6A ). The K R value of complex D, 7.56, was then used to extrapolate the molecular mass of complex D from the calibration curve. The results from this analysis revealed that complex D has a molecular mass of ∼130 kDa. To confirm these results, we performed in situ UV crosslinking of this complex. Analysis of the protein(s) in complex D which could be crosslinked to the D oligonucleotide indicated the presence of both a 62 and a 70 kDa protein species (Fig. 6B) . The sum of these molecular masses corresponds well to the molecular mass determined by native gel electrophoresis.
Abolishing complex D binding reduces transcriptional activation
In an attempt to gain some insight into the transcriptional properties of complex D, we established a series of minimal promoter vectors ( 4D), or M6 (which binds Sp1 but not complex D; Fig. 4F ). When these reporters were introduced into 293 cells, the presence of D elements upstream of the β-globin TATA box resulted in ∼140-fold activation, compared to the pβCAT reporter construct (Fig. 7B) . The presence of M4 sites upstream of the β-globin TATA box had no effect on CAT expression indicating that Sp1 and/or complex D binding is essential to the transcriptional effect imparted by D sites in pβCAT. Reporter pβCAT/6×M6 which contains elements capable of binding Sp1, but not complex D, showed a ∼35-fold activation, relative to pβCAT. This is a 4-fold lower effect than that observed with pβCAT/6×D. These results suggest that complex D may function as an activator, or may potentiate transcriptional activation of adjacent factors. Elucidating the mechanism of action of complex D will distinguish between these possibilities. We have not found any differences in the ability of Sp1 to interact with the D or M6 sites (Figs 4F and 7C and data not shown), thus decreased Sp1 binding to M6 is unlikely to be responsible for the observed effect.
DISCUSSION
In this report, we demonstrate that Sp1 is also able to bind to the CR element and have identified a novel binding activity which shows sequence specific binding to the D subfragment of the CR. Molecular mass determination experiments indicate that complex D consists of a ∼130 kDa complex, consisting of a heterodimer of at least two proteins, one of ∼62 and one of 70 kDa (Fig. 6 ). Alternatively, it is possible that complex D consists of a homodimer of ∼130-140 kDa whose subunits are ∼70 kDa. In this (Fig. 5) . These results suggest that competition for binding between Sp1 and complex D at this site may play a regulatory process in wt1 expression. Such a model for competitive binding with Sp1 has been characterized with a number of different transcription factors (18) (19) (20) (21) (22) (23) . These factors bind to sites that are adjacent to, or overlapping with, Sp1 binding sites, and promote the displacement of bound Sp1 due to steric effects. For example, Zif268 and Sp1 have overlapping binding sites in the murine adenosine deaminase (ADA) gene promoter (18) . Zif268 is able to downregulate expression from the ADA promoter by competing with Sp1 for binding to an overlapping motif (18) . In the platelet-derived growth factor (PDGF) A-chain gene promoter, there is a G+C rich region which contains overlapping binding sites for Sp1 and the transcription factor Egr-1 (19) . The induction of Egr-1 protein levels by phorbol-12-myristate-13-acetate (PMA) in vascular endothelial cells is correlated with a displacement of Sp1 from its site and increased binding of Egr-1 (19) . The rat growth hormone gene (rGH) promoter presents yet another example of transcriptional regulation at mutually exclusive binding sites (20) . Sp1 and Pit-1 bind overlapping sites in the rGH promoter in a mutually exclusive fashion, but both binding sites are essential for maximal expression of the rGH promoter in vivo. Other examples of promoter systems which undergo regulation via Sp1 occlusion at overlapping or adjacent sites include the ornithine decarboxylase (ODC) promoter (21), the collagen α1(I) promoter (22) and the gastrin promoter (23) .
Expression of wt1 is temporally and spatially regulated in the developing urogenital system, peaking at particular points during fetal development and then declining during maturation to adulthood (3, 4) . Complex D expression is not as restricted as is the expression of WT1 (Table 2) . Nuclear extracts were positive for complex D binding activity in all but one of 15 cell lines tested ( Table 2) . Of the 15 cell lines, WT1 is expressed in CEM (2), K562 (11, 12) , 293 (3), TM3 (J.P., unpublished observations), Cos-1 (24) and SVGC (J.P., unpublished observations) cells. The HeLa, ES, P19, NIH 3T3, LTA and L cells do not express WT1 (2, J.P., unpublished data). We are not aware of experiments characterizing the status of WT1 expression in C2C12, L6 and LR73 cells. Sp1 is also a ubiquitous transcription factor, but differences in the expression pattern of Sp1 and in the regulation of Sp1 activity suggest that Sp1 has a regulatory function in addition to a general role in the transcription of housekeeping genes. There is up to 100-fold difference in the amount of Sp1 present in different cell types (25) . In addition to competition for DNA binding, Sp1 activity can be regulated by a variety of mechanisms, including post-translational modification (26) (27) (28) (29) (30) and interaction with other proteins (31) (32) (33) .
A search for known transcription factors with the potential to bind to the CR revealed that the mammalian transcription factor LSF (Late SV40 Factor) was a good candidate for being a component of complex D. LSF is a 64 kDa protein which binds DNA as a dimer (34, 35) and is able to interact specifically and with similar affinities to different DNA sequences (34) . LSF binds strongly to GC-motifs 2 and 3 (the LSF-GC site) of the six GC-motifs in the 21 bp repeat region of the SV40 promoter, and bind to another sequence, designated LSF-280, where only half of the binding site contains a GC-motif (34, 35) . Competition between LSF and Sp1 within the SV40 promoter may be involved in regulating the switch from early to late transcription during an SV40 lytic infection (34) . EMSA competition experiments, using in vitro translated LSF protein, revealed that the D segment of the CR is not competent for binding LSF (M.T.D. and J.P., data not shown). These results indicate that LSF is not a component of complex D.
Elevated levels of Sp1 are associated with the differentiation process, and are the highest in developing hematopoietic cells, fetal cells and spermatids (25) . The human wt1 promoter shows 11 footprints for Sp1, and Sp1 has been shown to activate the wt1 promoter 3-4-fold (7). Cohen et al. (10) have identified one major Sp1 regulatory element, downstream of the first and second transcription initiation sites and ∼70 bp upstream of the third initiation site. They propose that putative Sp1 upregulation of wt1 during development could be mediated through this site. It is also possible that regulation of wt1 gene expression could involve a switch in wt1 transcription initiation site usage during development, generating wt1 transcripts with different 5′ untranslated regions. The effect of such a switch is currently unknown but could produce transcripts with altered translation initiation potential. It is clear that such an effect would be subtle since crude measurements of wt1 transcripts and protein have shown that both are coordinately expressed (36) . Similar to the transcriptional effect of Sp1 and Pit-1 at the rGH promoter (19) , our preliminary findings show that despite the mutually exclusive binding of Sp1 and complex D to the CR, the integrity of the complex D binding site is required for maximal activation of a reporter gene in transient transfections (Fig. 7) . One possible explanation for this is that regulation of wt1 may occur via a multistage mechanism where Sp1 and complex D bind the CR in a stepwise fashion. Also, increased binding of complex D to the CR may be involved in specific upregulation of wt1 expression at a particular time or in a particular tissue during development. Elucidating the precise role of complex D in regulating wt1 expression awaits the identification and characterization of the components of this complex.
